194 related articles for article (PubMed ID: 27608796)
1. Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study.
Talotta R; Berzi A; Atzeni F; Dell'Acqua D; Sarzi Puttini P; Trabattoni D
Reumatismo; 2016 Sep; 68(2):83-9. PubMed ID: 27608796
[TBL] [Abstract][Full Text] [Related]
2. The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses.
Talotta R; Berzi A; Doria A; Batticciotto A; Ditto MC; Atzeni F; Sarzi-Puttini P; Trabattoni D
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29023386
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy.
Coury F; Ferraro-Peyret C; Le Cam S; Guerin S; Tebib J; Sibilia J; Bienvenu J; Fabien N
Clin Exp Rheumatol; 2008; 26(2):234-9. PubMed ID: 18565243
[TBL] [Abstract][Full Text] [Related]
4. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
[TBL] [Abstract][Full Text] [Related]
5. Changes in the pattern of cytokine production from peripheral blood mononuclear cells in patients with rheumatoid arthritis treated with infliximab and their relation to plasma arginase activity.
Miyoshi F; Sato K; Mimura T
Int J Rheum Dis; 2018 Nov; 21(11):1907-1914. PubMed ID: 30592386
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis.
Ingegnoli F; Fantini F; Griffini S; Soldi A; Meroni PL; Cugno M
Clin Exp Rheumatol; 2010; 28(2):254-7. PubMed ID: 20483049
[TBL] [Abstract][Full Text] [Related]
8. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
Aeberli D; Seitz M; Jüni P; Villiger PM
Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
[TBL] [Abstract][Full Text] [Related]
9. Disease activity improvement in rheumatoid arthritis treated with tumor necrosis factor-α inhibitors correlates with increased soluble Fas levels.
Romano E; Terenzi R; Manetti M; Peruzzi F; Fiori G; Nacci F; Bellando-Randone S; Matucci-Cerinic M; Guiducci S
J Rheumatol; 2014 Oct; 41(10):1961-5. PubMed ID: 25179850
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis.
Blaschke S; Viereck V; Schwarz G; Klinger HM; Guerluek S; Müller GA
Scand J Rheumatol; 2009; 38(4):235-9. PubMed ID: 19247848
[TBL] [Abstract][Full Text] [Related]
11. Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.
Netea MG; Radstake T; Joosten LA; van der Meer JW; Barrera P; Kullberg BJ
Arthritis Rheum; 2003 Jul; 48(7):1853-7. PubMed ID: 12847679
[TBL] [Abstract][Full Text] [Related]
12. Changes in chemokines and their receptors in blood during treatment with the TNF inhibitor infliximab in patients with rheumatoid arthritis.
Eriksson C; Rantapää-Dahlqvist S; Sundqvist KG
Scand J Rheumatol; 2013; 42(4):260-5. PubMed ID: 23379516
[TBL] [Abstract][Full Text] [Related]
13. Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine Conditions.
Heim J; Almanzar G; Schmalzing M; Gernert M; Tony HP; Prelog M
Front Immunol; 2021; 12():668095. PubMed ID: 33995403
[TBL] [Abstract][Full Text] [Related]
14. Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vgamma9/Vdelta2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?
Giardina AR; Accardo-Palumbo A; Ciccia F; Ferrante A; Principato A; Impastato R; Triolo G
Reumatismo; 2009; 61(1):21-6. PubMed ID: 19370184
[TBL] [Abstract][Full Text] [Related]
15. Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis.
Braun-Moscovici Y; Markovits D; Zinder O; Schapira D; Rozin A; Ehrenburg M; Dain L; Hoffer E; Nahir AM; Balbir-Gurman A
J Rheumatol; 2006 Mar; 33(3):497-500. PubMed ID: 16511906
[TBL] [Abstract][Full Text] [Related]
16. Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.
Macías I; García-Pérez S; Ruiz-Tudela M; Medina F; Chozas N; Girón-González JA
J Rheumatol; 2005 Nov; 32(11):2102-8. PubMed ID: 16265686
[TBL] [Abstract][Full Text] [Related]
17. Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.
Detorakis EE; Magkanas E; Lasithiotaki I; Sidiropoulos P; Boumpas DT; Gourtsoyiannis N; Antoniou K; Raissaki M
Clin Exp Rheumatol; 2017; 35(1):43-52. PubMed ID: 27908307
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
19. Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha.
Baeten D; Van Damme N; Van den Bosch F; Kruithof E; De Vos M; Mielants H; Veys EM; De Keyser F
Ann Rheum Dis; 2001 Aug; 60(8):750-5. PubMed ID: 11454638
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment.
Toh ML; Marotte H; Blond JL; Jhumka U; Eljaafari A; Mougin B; Miossec P
Arthritis Rheum; 2006 Jul; 54(7):2109-18. PubMed ID: 16802346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
